•
GL
GLMD
Galmed Pharmaceuticals Ltd.
polygon--
Price Chart
Market Cap
4.46M
Volume
49.17K
52W High
$3.50
52W Low
$0.73
Open
$0.81
Prev Close
$0.81
Day Range
0.80 - 0.84
About Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
Latest News
Galmed Announces Meaningful Top Line Results from AM-001 Study of Aramchol Meglumine
Benzinga•Nov 18
Galmed Announces Digital Asset Management Strategy to Enhance Capital Efficiency and Drive Shareholder Value
Benzinga•Aug 25
Galmed Pharmaceuticals Launches VCU Collaboration to Tackle Drug Resistance in GI Cancers
Benzinga•Apr 17
Galmed Unveils Novel Pharmacodynamic Blood Markers for Aramchol, the Most Clinically Advanced SCD1 Inhibitor
Benzinga•Apr 15
Why Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket - Mainz Biomed ... - Benzinga
Benzinga•Jul 9
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Benzinga•Apr 10
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga•Apr 8
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Benzinga•Apr 8